Researchers are one step closer to testing an anti-cocaine vaccine in people. A novel vaccine developed by a team at Weill Cornell Medical College has shown success at reducing the amount of cocaine that reaches the brain. The vaccine was created by Cornell researchers and is made up of bits of the common cold virus with a particle that mimics the structure of cocaine, spurring an immune response that produces antibodies that target cocaine. Story